BioSpace News Archive

Genetown

Cambridge’s Scholar Rock Snags Another $47M to Take on Rare Neuromuscular Disease

The round was led by new investor Invus, with participation of another new investor, Redmile Group.

January 3, 2018
·
2 min read
·
Mark Terry
Biotech Bay

Spark’s Blindness-Curing Gene Therapy Comes With a $850,000 Price Tag

The therapy is the first type approved by the FDA that targets a disease caused by mutations in a specific gene.

January 3, 2018
·
3 min read
·
Alex Keown
Sansure Biotech Raises $77M in Funding Led by Lilly Asia

Sansure Biotech of Changsha raised $77M in a funding round led by Lilly Asia Ventures and Highlight Capital with participation from June Capital.

January 3, 2018
·
1 min read
Business

OvaScience Pinks Slips Nearly 50% of Workforce

OvaScience provided a corporate update that includes initial data from a Phase I trial and news of extensive layoffs.

January 3, 2018
·
2 min read
·
Mark Terry
Business

NYC Startup Syntimmune Names Former Biogen Exec as New CEO

Syntimmune has appointed Jean-Paul Kress as president and CEO.

January 3, 2018
·
2 min read
·
Mark Terry
Biotech Beach

New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures

The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures.

January 3, 2018
·
2 min read
·
Mark Terry
Deals

Boas Surgical Just Opened Its 10th Office

The nearly 100-year-old medical-device business manufactures prosthetics and orthotics such as foot inserts and knee braces.

January 3, 2018
·
1 min read
BioCapital

Medical Device Tax to Resume After 2-Year Hiatus

The tax was strongly opposed by the $150 billion a year industry that produces everything from catheters to heart stents to artificial joints

January 3, 2018
·
1 min read
CMAB Closes $38M Series A Financing Round

The company will provide services for development of manufacturing processes, analytical methods, formulation, and manufacture of biologic drug substances and drug products.

January 3, 2018
·
3 min read
Business

Allergan to Slash 1,000+ Jobs

Allergan will cut about 5 percent of its workforce, as the company looks to cut costs due to increased pipeline competition and loss of exclusivity on some products.

January 3, 2018
·
2 min read
·
Alex Keown